Plasma prekallikrein, factor XII, antithrombin III, C1(-)-inhibitor and alpha 2-macroglobulin in critically ill patients with suspected disseminated intravascular coagulation (DIC).
In nine patients with suspected disseminated intravascular coagulation (DIC) and five controls, the following analyses were performed on admission and 7-29 hours later: Routine coagulation studies (fibrinogen, platelet count, fibrin(ogen) degradation products, ethanol gelation, reptilase time, Factor V) providing a semiquantitative DIC score, prekallikrein (PK), Factor XII, antithrombin III (AT-III), C1(-)-inhibitor and alpha 2-macroglobulin. Significant correlations were found: PK or AT III with the DIC-score, PK with AT-III and Factor XII, AT-III with Factor XII. The changes (expressed as a percentage of normal plasma) of PK and AT-III from the first to the second evaluation were nearly identical. The two patients with rapidly fatal irreversible shock showed the highest DIC score and a pronounced decrease of PK and AT-III, whereas in reversible shock stable or increasing PK and AT-III values were found. The other variables showed an overlap between reversible and irreversible shock. DIC in these shock patients, accompanied by a decrease in PK, probably was mediated via Factor XII activation. PK and AT-III might be of prognostic value in patients with (septic) shock.
D000368:Aged; D000990:Antithrombin III / Q000032:analysis*; D003174:Complement C1 Inactivator Proteins / Q000032:analysis*; D003422:Critical Care; D004211:Disseminated Intravascular Coagulation / Q000097:blood*; D005174:Factor XII / Q000032:analysis*; D005260:Female; D005340:Fibrinogen / Q000032:analysis; D006801:Humans; D007610:Kallikreins / Q000032:analysis*; D008297:Male; D008875:Middle Aged; D011288:Prekallikrein / Q000032:analysis*; D011379:Prognosis; D000511:alpha-Macroglobulins / Q000032:analysis*
D003174:Complement C1 Inactivator Proteins; D000511:alpha-Macroglobulins; D000990:Antithrombin III; D005174:Factor XII; D005340:Fibrinogen; D011288:Prekallikrein; D007610:Kallikreins